Breaking News Instant updates and real-time market news.

DISCA

Discovery

$26.40

0.18 (0.69%)

, AMCX

AMC Networks

$57.20

0.47 (0.83%)

09:17
07/18/17
07/18
09:17
07/18/17
09:17

Discovery CEO says media companies must 'disrupt' themselves

In an interview earlier on CNBC, Discovery Communications CEO David Zaslav said the company and its peers have a choice, namely: "We can hold onto our existing business or try and do some of these new forms of content. Or we can figure out how to disrupt ourselves." CNBC has posted a replay of Zaslav's interview to its site. Discovery peers include AMC Networks (AMCX) and Scripps Networks (SNI). Reference Link

DISCA

Discovery

$26.40

0.18 (0.69%)

AMCX

AMC Networks

$57.20

0.47 (0.83%)

SNI

Scripps Networks

$68.22

0.48 (0.71%)

  • 09

    Aug

DISCA Discovery
$26.40

0.18 (0.69%)

06/26/17
SBSH
06/26/17
NO CHANGE
SBSH
Buy
21st Century Fox valuation discount to peers is 'odd,' says Citi
Citi analyst Jason Bazinet calls 21st Century Fox's (FOXA) valuation discount to peers like Scripps Networks (SNI) and Discovery (DISCA) "odd." Fox is both structurally better positioned than peers and has less advertising exposure, Bazinet tells investors in a research note. He believes 2018 consensus estimates for the company are "fairly achievable" and keeps a Buy rating on the shares.
04/20/17
SBSH
04/20/17
UPGRADE
Target $30
SBSH
Neutral
Discovery upgraded to Neutral from Sell at Citi
Citi analyst Jason Bazinet upgraded Discovery Communications to Neutral saying he sees little chance of material downward revisions to consensus earnings estimates. The analyst views the risk/reward as more balanced at current levels and upped his price target for the shares to $30 from $27.
04/20/17
04/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Starbucks (SBUX) upgraded to Buy from Hold at Stifel with analyst Mark Astrachan saying he views valuation as attractive and expects multiple expansion from accelerating U.S. comparable store sales growth to at least 5%-6% for the next four quarters starting in the June quarter. The analyst said shares have underperformed consumer and restaurant peers over the past 12 months and expects outperformance to be driven by meeting comp expectations. 2. Goldman Sachs (GS) upgraded to Overweight from Neutral at Atlantic Equities with analyst Christopher Wheeler telling investors investors shares are "oversold." The analyst expects the FICC business to bounce back and made just a small reduction in estimates to account for further cost measures. 3. Lear (LEA) upgraded to Outperform from Neutral at Baird with analyst David Leiker citing its recent underperformance despite improving fundamentals and a strong global auto backdrop. Leiker raised his price target to $161 from $160 on Lear shares. 4. Discovery (DISCA) upgraded to Neutral from Sell at Citi with analyst Jason Bazinet saying he sees little chance of material downward revisions to consensus earnings estimates. The analyst views the risk/reward as more balanced at current levels and upped his price target for the shares to $30 from $27. 5. Gap (GPS) upgraded to Neutral from Underweight at JPMorgan with analyst Matthew Boss citing the underperformance of the shares over the past 18 months and his fieldwork which suggests stability at Old Navy. The analyst raised his price target for the shares to $24 from $21. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/19/17
RBCM
05/19/17
NO CHANGE
RBCM
Discovery likely to make deal, says RBC Capital
As the situation deteriorates for media companies due to accelerating cord cutting and weak ad trends, RBC Capital analyst Steven Cahall thinks that companies in the sector will look to consolidate. He thinks that Discovery (DISCA) will likely look to combine with either Lionsgate (LGF.A,LGF.B) or Charter (CHTR) and could look to combine with Scripps Networks (SNI).
AMCX AMC Networks
$57.20

0.47 (0.83%)

04/10/17
04/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) downgraded to Hold from Buy at Jefferies with analyst Jeffrey Holford citing the impact of future revenue externalizations and asset disposals on revenue and earnings growth. Consensus estimates may overestimate revenue by up to $2.5B and core operating profit by up to $850M by 2021, Holford tells investors in a research note. 2. J.M. Smucker (SJM) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Matthew Grainger saying increased retail competition adds to a challenging US Foods backdrop. The analyst sees two headwinds emerging from Wal-Mart's (WMT) increased leverage over Food manufacturers and renewed private label growth. Grainger said J.M. Smucker's has outsized risk to Wal-Mart and private label risk , and as a result downgraded shares and lowered his price target to $126 from $132. 3. Marriott (MAR) downgraded to Buy from Conviction Buy at Goldman with analyst Stephen Grambling citing outperformance versus the S&P since adding shares to the Conviction Buy List on September 25, 2016. 4. AMC Networks (AMCX) downgraded to Neutral from Overweight at Piper Jaffray with analyst Stan Meyers citing viewership declines at the flagship Walking Dead franchise, "quickly accelerating" content and marketing costs as well as his firm's teen survey which indicated teens are turning away from cable at a faster pace. The analyst cut his price target AMC shares to $60 from $73. 5. Cinemark (CNK) downgraded to Buy from Conviction Buy at Goldman with analyst Michael Ng citing valuation and maintained its Buy rating and $49 price target. The analyst expects Cinemark to outperform box office growth in 2017 given its aggressive rollout of recliners across its US footprint in 2016. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/24/17
02/24/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wendy's (WEN) upgraded to Overweight from Neutral at JPMorgan with analyst John Ivankoe saying the shares are attractive around the $13.50 level. The analyst likes the moves by the new management team and keeps a $15 price target for the shares. 2. AMC Networks (AMCX) upgraded to Buy from Hold at Stifel with analyst Benjamin Mogil saying better than expected ad monetization, despite materially down Walking Dead ratings, indicates strength outside of that window and the continued appeal of the shows attractiveness in a fragmented market. 3. Chesapeake (CHK) upgraded to Neutral from Sell at UBS with analyst William Featherston citing valuation with the stock below his $6 price target as well as the company's improved liquidity position. 4. Intuit (INTU) upgraded to Outperform from Neutral at Credit Suisse with analyst Michael Nemeroff citing his expectations for a normal close to the 2016 tax season, in which he expects the company to at least maintain its share of the tax prep market and continued strong growth in its small business segment, particularly given new and expanded partnerships with financial institutions such as JPMorgan Chase (JPM), Wells Fargo (WFC), and others. The analyst also raised his price target on Intuit's shares to $140 from $109. 5. Helmerich & Payne (HP) upgraded to Buy from Neutral at BofA/Merrill with analyst Timna Tanners saying he expects land rig pricing power to improve due to increasing US land rig count and increased E&P capex plans. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/24/17
STFL
02/24/17
UPGRADE
Target $70
STFL
Buy
AMC Networks upgraded to Buy from Hold at Stifel
Stifel analyst Benjamin Mogil upgraded AMC Networks to Buy and raised its price target to $70 from $56 following the Q4 conference call. The analyst said better than expected ad monetization, despite materially down Walking Dead ratings, indicates strength outside of that window and the continued appeal of the shows attractiveness in a fragmented market.
04/10/17
PIPR
04/10/17
DOWNGRADE
Target $60
PIPR
Neutral
AMC Networks downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Stan Meyers downgraded AMC Networks to Neutral citing viewership declines at the flagship Walking Dead franchise, "quickly accelerating" content and marketing costs as well as his firm's teen survey which indicated teens are turning away from cable at a faster pace. The analyst cut his price target AMC shares to $60 from $73.
SNI Scripps Networks
$68.22

0.48 (0.71%)

05/05/17
JPMS
05/05/17
UPGRADE
Target $83
JPMS
Overweight
Scripps Networks upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Alexia Quadrani upgraded Scripps Networks Interactive to Overweight citing the 10% pullback in the shares over the past month. The analyst notes Scripps offered "strong commentary" on ad revenue and is now included in Hulu Live. She keeps an $83 price target for the shares.
05/05/17
05/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Zynga (ZNGA) upgraded to Neutral from Underperform at BofA/Merrill with analyst Justin Post citing stronger engagement that is driving bookings growth. 2. Hess Corp. (HES) upgraded to Outperform from Market Perform at Wells Fargo citing what it sees as Hess' "growth potential, strong operating cost performance, balance sheet strength, exploration upside and current discounted valuation." Wells expects the company to grow at a compound annual rate of 4.9% through 2019. 3. CF Industries (CF) upgraded to Buy from Neutral at UBS with analyst John Roberts saying the stock is a top pick on the eventual agricultural recovery. Limited nitrogen capacity coming post 2017 and the dividend yield position the stock for upside, Roberts tells investors in a research note. The analyst keeps a $33 price target for the shares. 4. TreeHouse (THS) upgraded to Overweight from Equal Weight at Stephens. 5. Scripps Networks (SNI) upgraded to Overweight from Neutral at JPMorgan with analyst Alexia Quadrani citing the 10% pullback in the shares over the past month. The analyst notes Scripps offered "strong commentary" on ad revenue and is now included in Hulu Live. She keeps an $83 price target for the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

STLD

Steel Dynamics

$37.78

1.34 (3.68%)

21:35
10/19/17
10/19
21:35
10/19/17
21:35
Upgrade
Steel Dynamics rating change  »

Steel Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

RXDX

Ignyta

$16.65

0.4 (2.46%)

20:30
10/19/17
10/19
20:30
10/19/17
20:30
Syndicate
Ignyta 10M share Secondary priced at $16.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 20

    Oct

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

, GE

General Electric

$23.58

0.46 (1.99%)

20:25
10/19/17
10/19
20:25
10/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

GE

General Electric

$23.58

0.46 (1.99%)

HON

Honeywell

$143.62

0.18 (0.13%)

SLB

Schlumberger

$64.50

-1.41 (-2.14%)

STI

SunTrust

$59.11

-0.18 (-0.30%)

SYF

Synchrony

$31.71

0.2 (0.63%)

CFG

Citizens Financial

$37.43

0.25 (0.67%)

KSU

Kansas City Southern

$103.78

0.97 (0.94%)

GNTX

Gentex

$20.66

0.2 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 02

    Nov

WILC

G. Willi-Food

$5.85

-0.14 (-2.34%)

18:35
10/19/17
10/19
18:35
10/19/17
18:35
Hot Stocks
G. Willi-Food receives notice from Arla Food ending distribution agreement »

G. Willi-Food's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$71.26

-0.46 (-0.64%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Macquarie Infrastructure CEO to become CEO of Macquarie Atlas Roads in 2018 »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

BIDU

Baidu

$264.52

-4.45 (-1.65%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Baidu collaborating with China's BAIC Group and King Long for autonomous driving »

Baidu signed strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

IBKC

Iberiabank

$80.15

0.05 (0.06%)

18:27
10/19/17
10/19
18:27
10/19/17
18:27
Hot Stocks
IBERIABANK to acquire Gibraltar Private Bank & Trust »

IBERIABANK Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

VBTX

Veritex

$27.04

-0.02 (-0.07%)

18:20
10/19/17
10/19
18:20
10/19/17
18:20
Hot Stocks
Veritex receives regulatory approval for Liberty Bancshares merger »

Veritex Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BHP

BHP Billiton

$41.56

0.06 (0.14%)

18:03
10/19/17
10/19
18:03
10/19/17
18:03
Hot Stocks
BHP Billiton CEO sees challenges around geopolitical uncertainty remaining »

In annual shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRRX

Durect

$1.97

0.03 (1.55%)

17:59
10/19/17
10/19
17:59
10/19/17
17:59
Hot Stocks
Durect: Phase 3 clinical trial for POSIMIR did not meet primary endpoint »

Durect reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTNP

Titan Pharmaceuticals

$1.90

-0.1 (-5.00%)

17:49
10/19/17
10/19
17:49
10/19/17
17:49
Hot Stocks
Titan Pharmaceuticals presents non-clinical data from liothyronine implant »

Titan Pharmaceuticals is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$82.20

1.37 (1.69%)

17:46
10/19/17
10/19
17:46
10/19/17
17:46
Earnings
MSA Safety reports Q3 EPS 92c, consensus 80c »

Reports Q3 revenue $296M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

SKX

Skechers

$24.03

-1.06 (-4.22%)

, CAI

CAI International

$31.38

-0.05 (-0.16%)

17:41
10/19/17
10/19
17:41
10/19/17
17:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SKX

Skechers

$24.03

-1.06 (-4.22%)

CAI

CAI International

$31.38

-0.05 (-0.16%)

PYPL

PayPal

$67.25

-0.01 (-0.01%)

MXIM

Maxim Integrated

$50.09

0.24 (0.48%)

IMDZ

Immune Design

$5.50

-1.05 (-16.03%)

NCR

NCR Corp.

$37.05

-0.26 (-0.70%)

TACO

Del Taco

$15.39

-0.01 (-0.06%)

ATHN

athenahealth

$116.41

-4.37 (-3.62%)

ISRG

Intuitive Surgical

$357.46

3.09 (0.87%)

ETFC

E-Trade

$43.69

-0.23 (-0.52%)

CELG

Celgene

$135.96

-1.21 (-0.88%)

PBMD

Prima BioMed

$2.36

-0.02 (-0.84%)

AAXN

Axon

$24.62

-0.37 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 21

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 29

    Nov

DGX

Quest Diagnostics

$93.23

1.18 (1.28%)

17:37
10/19/17
10/19
17:37
10/19/17
17:37
Hot Stocks
Quest Diagnostics acquires Cleveland HeartLab, terms not disclosed »

Advantage Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

  • 30

    Nov

AAXN

Axon

$24.62

-0.37 (-1.48%)

17:34
10/19/17
10/19
17:34
10/19/17
17:34
Hot Stocks
Axon says now aware of comment letter over SEC's review of 10-K, 10-Q »

Axon Enterprise said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on BioPharmX »

BioPharmX files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$0.74

0.0248 (3.47%)

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on MabVax Therapeutics »

MabVax Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$80.15

0.05 (0.06%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Earnings
Iberiabank reports Q3 non-GAAP EPS $1.00, consensus $1.16 »

Reports Q3 core revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

DRRX

Durect

$1.97

0.03 (1.55%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Hot Stocks
Breaking Hot Stocks news story on Durect »

Durect trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCP

Quality Care Properties

$16.26

0.07 (0.43%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Quality Care Properties provides update on HCR ManorCare »

Quality Care Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$11.48

0.02 (0.17%)

, CHH

Choice Hotels

$68.45

0.25 (0.37%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Frontier Communications named a Qualified Vendor with Choice Hotels Internationa »

Frontier Communications…

FTR

Frontier Communications

$11.48

0.02 (0.17%)

CHH

Choice Hotels

$68.45

0.25 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 08

    Nov

DRIO

DarioHealth

$1.98

-0.2 (-9.17%)

17:16
10/19/17
10/19
17:16
10/19/17
17:16
Syndicate
Breaking Syndicate news story on DarioHealth  »

DarioHealth files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBI

Customers Bancorp

$33.16

0.46 (1.41%)

17:11
10/19/17
10/19
17:11
10/19/17
17:11
Hot Stocks
Customers Bancorp to spin off BankMobile business »

Customers Bancorp plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 15

    Nov

MVC

MVC Capital

$10.40

0.08 (0.78%)

17:07
10/19/17
10/19
17:07
10/19/17
17:07
Hot Stocks
MVC Capital: Glass Lewis, Egan-Jones against proposal to cease new investments »

MVC Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CELG

Celgene

$135.96

-1.21 (-0.88%)

17:05
10/19/17
10/19
17:05
10/19/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Celgene »

Celgene down 6.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.